FIVE PRIME THERAPEUTICS INC's ticker is FPRX and the CUSIP is 33830X104. A total of 99 filers reported holding FIVE PRIME THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $13,790,000 | +109.3% | 366,059 | -5.5% | 0.00% | +200.0% |
| Q4 2020 | $6,588,000 | +297.8% | 387,256 | +10.0% | 0.00% | – |
| Q3 2020 | $1,656,000 | -25.1% | 352,176 | -2.9% | 0.00% | -100.0% |
| Q2 2020 | $2,212,000 | +128.3% | 362,656 | -15.0% | 0.00% | – |
| Q1 2020 | $969,000 | -46.6% | 426,650 | +7.9% | 0.00% | – |
| Q4 2019 | $1,815,000 | +10.0% | 395,377 | -7.2% | 0.00% | – |
| Q3 2019 | $1,650,000 | -38.2% | 426,029 | -3.9% | 0.00% | -100.0% |
| Q2 2019 | $2,672,000 | -53.7% | 443,191 | +2.8% | 0.00% | 0.0% |
| Q1 2019 | $5,777,000 | +45.9% | 431,137 | +1.3% | 0.00% | 0.0% |
| Q4 2018 | $3,959,000 | -32.8% | 425,775 | +0.5% | 0.00% | 0.0% |
| Q3 2018 | $5,895,000 | -5.6% | 423,497 | +7.2% | 0.00% | -50.0% |
| Q2 2018 | $6,243,000 | -1.8% | 394,878 | +6.7% | 0.00% | 0.0% |
| Q1 2018 | $6,357,000 | -10.3% | 370,040 | +14.5% | 0.00% | 0.0% |
| Q4 2017 | $7,087,000 | -46.2% | 323,298 | +0.3% | 0.00% | -33.3% |
| Q3 2017 | $13,185,000 | +30.5% | 322,284 | -3.9% | 0.00% | 0.0% |
| Q2 2017 | $10,102,000 | -15.8% | 335,488 | +1.1% | 0.00% | 0.0% |
| Q1 2017 | $11,991,000 | -27.6% | 331,718 | +0.4% | 0.00% | -40.0% |
| Q4 2016 | $16,558,000 | -6.6% | 330,456 | -2.2% | 0.01% | -16.7% |
| Q3 2016 | $17,727,000 | +31.9% | 337,743 | +3.9% | 0.01% | +50.0% |
| Q2 2016 | $13,435,000 | +17.7% | 324,934 | +8.3% | 0.00% | 0.0% |
| Q1 2016 | $11,417,000 | -7.4% | 299,993 | +0.9% | 0.00% | 0.0% |
| Q4 2015 | $12,333,000 | +194.6% | 297,180 | +9.3% | 0.00% | +300.0% |
| Q3 2015 | $4,186,000 | -28.3% | 271,946 | +15.8% | 0.00% | -50.0% |
| Q2 2015 | $5,836,000 | +17.8% | 234,928 | +8.4% | 0.00% | +100.0% |
| Q1 2015 | $4,954,000 | +10.9% | 216,808 | +31.1% | 0.00% | 0.0% |
| Q4 2014 | $4,466,000 | +127.7% | 165,415 | -1.1% | 0.00% | 0.0% |
| Q3 2014 | $1,961,000 | +42.8% | 167,172 | +89.4% | 0.00% | – |
| Q2 2014 | $1,373,000 | -5.5% | 88,276 | +19.6% | 0.00% | – |
| Q1 2014 | $1,453,000 | +12.1% | 73,840 | -4.3% | 0.00% | – |
| Q4 2013 | $1,296,000 | – | 77,167 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|